Department of Burn and Plastic Surgery, The Fourth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, 100038, China; 7th Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 10005, China.
Department of Burn and Plastic Surgery, The Fourth Medical Centre, Chinese PLA (People's Liberation Army) General Hospital, Beijing, 100038, China.
Chin J Traumatol. 2022 Jul;25(4):218-223. doi: 10.1016/j.cjtee.2022.03.006. Epub 2022 Apr 2.
The proposed pathological mechanism for scar formation is controversial, and increased attention has been paid to the fatty acids (FAs) in the formation of pathological scars. Notably, FAs are known to be important in inflammation and mechanotransduction, which is closely related to scar formation. Therefore, it is necessary to clarify the roles of FA in scar formation.
Hypertrophic scar and keloid formed for more than a year and without other treatment, as well as normal skin samples were obtained from patients who underwent plastic surgery. Finally, keloids (n = 10), hypertrophic scars (n = 10), and normal skin samples (n = 10) were collected under informed consent. Primary dermal fibroblasts were isolated and cultured. The amount and variety of FAs were detected by lipid chromatography-mass spectrometry. Immunohistochemistry, real-time PCR, and western blotting were used to verify the expression of sterol regulatory element-binding protein-1 (SREBP1) and fatty acid synthase (FASN) in the samples and their fibroblasts. Student's t-test, ANOVA, and orthogonal partial least square discriminant analysis were performed for statistical analysis (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001).
Compared with full-thickness normal skin, there were 27 differential FAs in keloids and 15 differential FAs in hypertrophic scars (∗p < 0.05 and variable influence on projection >1.0). The expression of SREBP1 and FASN was lower in pathological scars both at mRNA and protein levels (all ∗p < 0.05). However, the mRNA levels of SREBP1 (∗∗∗p = 0.0002) and FASN (∗∗∗p = 0.0021) in keloid-derived fibroblasts were higher than that in normal skin fibroblasts (NFBs), while the expression in hypertrophic scar-derived fibroblasts was lower than that in NFBs (both ∗p < 0.05). Whereas there was no significant difference in FASN protein expression between keloid-derived fibroblasts and NFBs (p > 0.05).
FAs involved in pathological scars are abnormally changed in scar formation. Thus, fatty acid-derived inflammation and de novo synthesis pathway of FA may play a key role in the formation of pathological scars.
瘢痕形成的病理机制尚存在争议,人们越来越关注脂肪酸(FA)在病理性瘢痕形成中的作用。众所周知,FA 参与炎症和机械转导,而这与瘢痕形成密切相关。因此,有必要阐明 FA 在瘢痕形成中的作用。
收集整形手术后患者的增生性瘢痕和瘢痕疙瘩(形成时间超过 1 年且未经其他治疗)以及正常皮肤样本。最终,征得患者知情同意后,收集瘢痕疙瘩(n=10)、增生性瘢痕(n=10)和正常皮肤样本(n=10)。分离并培养原代真皮成纤维细胞。采用脂质色谱-质谱法检测 FA 的含量和种类。免疫组织化学、实时 PCR 和 Western blot 用于验证样本及其成纤维细胞中固醇调节元件结合蛋白-1(SREBP1)和脂肪酸合酶(FASN)的表达。采用 Student's t-test、ANOVA 和正交偏最小二乘判别分析进行统计分析(∗p<0.05,∗∗p<0.01,∗∗∗p<0.001,∗∗∗∗p<0.0001)。
与全厚正常皮肤相比,瘢痕疙瘩中有 27 种差异 FA,增生性瘢痕中有 15 种差异 FA(∗p<0.05,投影变量影响>1.0)。SREBP1 和 FASN 的 mRNA 和蛋白水平在病理性瘢痕中表达均降低(均 ∗p<0.05)。然而,瘢痕疙瘩来源的成纤维细胞中 SREBP1(∗∗∗p=0.0002)和 FASN(∗∗∗p=0.0021)的 mRNA 水平高于正常皮肤成纤维细胞(NFBS),而增生性瘢痕来源的成纤维细胞中 SREBP1 和 FASN 的表达低于 NFBS(均 ∗p<0.05)。然而,瘢痕疙瘩来源的成纤维细胞中 FASN 蛋白表达与 NFBS 之间无显著差异(p>0.05)。
病理性瘢痕中涉及的 FA 在瘢痕形成过程中发生异常改变。因此,FA 衍生的炎症和 FA 从头合成途径可能在病理性瘢痕形成中发挥关键作用。